1-9 of 9
patient simulation
Close
Sort by
Journal Articles

Are OSCE Standardized Patients with Actual Sickle Cell Disease More Believable and Beneficial Than Actors Portraying Same Scenarios?

Kitty Carter-Wicker, MD, Ovie Utuama, MDMPH, Ona Utuama, MDMPH, Tom Adamkiewicz, MD FRCPC, MSc, Khadeja Johnson, MD, Janice Hall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5573.
https://doi.org/10.1182/blood.V130.Suppl_1.5573.5573
Published: 2017
Journal Articles

More Efficient Exchange of Sickle Red Blood Cells Can be Achieved By Exchanging the Densest Red Blood Cells

Suzanne Thibodeaux, MDPhD, Leah Irwin, RN, MSN, CRNP, Lita Jamensky, RN, Kevin Schell, RN, Una O'Doherty, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3856.
https://doi.org/10.1182/blood.V128.22.3856.3856
Published: 2016
Journal Articles

Personalized Therapy Design for MPN Using Predictive Simulation Methodology with in Vitro, Ex Vivo, and in Vivo Validatio

Peter P. Sayeski, PhD, Shireen Vali, PhD, Ansu Kumar, Sung Park, PhD, Neeraj Kumar Singh, Anuj Tyagi, Taher Abbasi, MS, Christopher R. Cogle, MD
Journal: Blood
Blood (2014) 124 (21): 3212.
https://doi.org/10.1182/blood.V124.21.3212.3212
Published: 2014
Journal Articles

CD4+ T Cells in High-Risk MDS Patients Bear an Aberrant STAT Signaling Biosignature

Eleftheria Lamprianidou, Constantinos Tsatalas, Paraskevi Miltiades, Theodoros P. Vassilakopoulos, Sotirios G Papageorgiou, MD, Athanasios G. Galanopoulos, Sofia Vakalopoulou, MD Ass.Prof.Hematology, Vassilia Garypidou, Evangelia Nakou, Emmanuil Spanoudakis, Ioannis Kotsianidis
Journal: Blood
Blood (2014) 124 (21): 1906.
https://doi.org/10.1182/blood.V124.21.1906.1906
Published: 2014
Journal Articles

Therapy Personalization Using Predictive Simulation Approach with Ex-Vivo Clinical Validations

Nicole A Doudican, PhD, Ravi Vij, MD, Mark A Fiala, BS, CCRP, Justin King, Shireen Vali, PhD, Kabya Basu, Ansu Kumar, Neeraj Kumar Singh, Zeba Sultana, Taher Abbasi, MS, Amitabha Mazumder, MD
Journal: Blood
Blood (2014) 124 (21): 2232.
https://doi.org/10.1182/blood.V124.21.2232.2232
Published: 2014
Journal Articles

Distinct Profile and Epigenetic Modulation Of STAT Signaling In FOXP3+ T Regulatory Cells Among The Various MDS Subtypes

Eleftheria Lamprianidou, Costas Tsatalas, Paraskevi Miltiades, Theodoros Vassilakopoulos, Athanasios G. Galanopoulos, Sotirios G Papageorgiou, Vassilia Garypidou, Sofia Vakalopoulou, MD, Emmanouil Spanoudakis, Dimitrios Margaritis, Ioannis Kotsianidis
Journal: Blood
Blood (2013) 122 (21): 1509.
https://doi.org/10.1182/blood.V122.21.1509.1509
Published: 2013
Journal Articles

Estimating Long-Term Life Expectancy in Philadelphia Chromosome Positive (Ph+) Chronic Phase Chronic Myeloid Leukemia (CML-CP): Results of A Microsimulation Model

Sonya J Snedecor, PhD, Xiang Ji, MS, Matthew Magestro, Andrew M Stein, PhD, Marc Botteman, MSc, MA
Journal: Blood
Blood (2012) 120 (21): 4441.
https://doi.org/10.1182/blood.V120.21.4441.4441
Published: 2012
Journal Articles

Erythroid Response (ER) Rates in Myelodysplastic Syndromes (MDS) Patients Treated with Epoetin Alfa (EPO) or Darbepoetin Alfa (DARB) Using International Working Group Response Criteria (IWGc): Comparative Meta-Analysis.

Suneel Mundle, PhD, Patrick Lefebvre, MA, Mei S. Duh, MPH, ScD, Ahmed Bourezak, MA, Behin Yektashenas, PharmD, Victor Moyo, MD
Journal: Blood
Blood (2006) 108 (11): 2672.
https://doi.org/10.1182/blood.V108.11.2672.2672
Published: 2006
Journal Articles

Soluble Monomeric P-Selectin Containing Only the Lectin and Epidermal Growth Factor Domains Binds to P-Selectin Glycoprotein Ligand-1 on Leukocytes

Padmaja Mehta, Kamala D. Patel, Thomas M. Laue, Harold P. Erickson, Rodger P. McEver
Journal: Blood
Blood (1997) 90 (6): 2381–2389.
https://doi.org/10.1182/blood.V90.6.2381
Published: 1997